Trial · NCT04837885
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Standardized uptake value (SUVmax) on liver metastases | Day 0 (First PET/CT) | Standardized uptake value (SUVmax) on liver metastase obtained on PET/CT imaging after injection of 68Ga-DOTA-peptides |
| Primary | Standardized uptake value (SUVmax) on liver metastases | Day 3 (second PET/CT) | Standardized uptake value (SUVmax) on liver metastase obtained on PET/CT imaging after injection of 68Ga-DOTA-peptides |
| Secondary | Standardized uptake value (SUVmax) on healthy liver | Day 0 (First PET/CT) | Standardized uptake value (SUVmax) on healthy liver obtained on PET/CT imaging after injection of 68Ga-DOTA-peptides |
| Secondary | Standardized uptake value (SUVmax) on healthy liver | Day 3 (second PET/CT) | Standardized uptake value (SUVmax) on healthy liver obtained on PET/CT imaging after injection of 68Ga-DOTA-peptides |
| Secondary | Standardized uptake value (SUVmax) on kidneys | Day 0 (First PET/CT) | Standardized uptake value (SUVmax) on kidneys obtained on PET/CT imaging after injection of 68Ga-DOTA-peptides |
| Secondary | Standardized uptake value (SUVmax) on kidneys | Day 3 (second PET/CT) | Standardized uptake value (SUVmax) on kidneys obtained on PET/CT imaging after injection of 68Ga-DOTA-peptides |
| Secondary | Standardized uptake value (SUVmax) on bone marrow | Day 0 (First PET/CT) | Standardized uptake value (SUVmax) on bone marrow obtained on PET/CT imaging after injection of 68Ga-DOTA-peptides |
| Secondary | Standardized uptake value (SUVmax) on bone marrow | Day 3 (second PET/CT) | Standardized uptake value (SUVmax) on bone marrow obtained on PET/CT imaging after injection of 68Ga-DOTA-peptides |
| Secondary | Standardized uptake value (SUVmax) on spleen | Day 0 (First PET/CT) | Standardized uptake value (SUVmax) on spleen obtained on PET/CT imaging after injection of 68Ga-DOTA-peptides |
| Secondary | Standardized uptake value (SUVmax) on spleen | Day 3 (second PET/CT) | Standardized uptake value (SUVmax) on spleen obtained on PET/CT imaging after injection of 68Ga-DOTA-peptides |
| Secondary | Standardized uptake value (SUVmax) on associated extra-hepatic metastases | Day 0 (First PET/CT) | Standardized uptake value (SUVmax) on associated extra-hepatic metastases obtained on PET/CT imaging after injection of 68Ga-DOTA-peptides |
| Secondary | Standardized uptake value (SUVmax) on associated extra-hepatic metastases | Day 3 (second PET/CT) | Standardized uptake value (SUVmax) on associated extra-hepatic metastases obtained on PET/CT imaging after injection of 68Ga-DOTA-peptides |
| Secondary | 177Lu-DOTA-peptide dosimetry | Day 18 | Absorbed dose in different tissue of the 5 hepatic targets, possible extra-hepatic lesions and healthy organs (healthy liver, kidney, bone marrow, spleen) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04837885/registered